Six months after launch, Rhizome AI has doubled the countries covered, tripled its user base, and achieved 5x revenue growth.
The company also announced a complimentary free plan, offering exhaustive and traceable answers to aid regulatory decision-making for drug and medical device builders.
Rhizome AI is an AI-powered regulatory intelligence platform designed for life sciences, pharmaceutical, and biotech companies.
It acts as an automated "regulatory coworker" that searches primary health authority databases to answer complex compliance, clinical, and regulatory questions.